RT
TEVA icon

Reliance Trust’s Teva Pharmaceuticals TEVA Stock Holding History

Reliance Trust’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-8,439
Closed -$485K – 112
2014
Q4 		$485K Sell
8,439
-206
-2% -$11.5K 0.56% 56
2014
Q3 		$465K Buy
8,645
+303
+4% +$16.1K 0.54% 55
2014
Q2 		$437K Sell
8,342
-366
-4% -$18.7K 0.49% 64
2014
Q1 		$460K Buy
8,708
+509
+6% +$23.5K 0.45% 66
2013
Q4 		$328K Buy
8,199
+1,857
+29% +$73.1K 0.31% 86
2013
Q3 		$240K Sell
6,342
-1,985
-24% -$77.4K 0.23% 124
2013
Q2 		$326K Buy
+8,327
New +$324K 0.21% 108

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Reliance Trust's TEVA Position: Q1 2015 in Review

Reliance Trust sold out of Teva Pharmaceuticals (TEVA) in Q1 2015, closing a stake of 8,439 shares — an estimated $485K sold.

Reliance Trust first reported a position in TEVA in Q2 2013 and held it in 7 quarters. The position peaked at $485K in Q4 2014. 822 funds tracked by Wall St. Rank hold TEVA as of Q1 2015.

  • Reliance Trust reported no remaining Teva Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
  • Reliance Trust sold 8,439 Teva Pharmaceuticals shares in Q1 2015, an estimated $485K.
  • Reliance Trust first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 7 quarters.
  • Reliance Trust's Teva Pharmaceuticals position peaked at $485K in Q4 2014.
  • 822 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2015.

Based on Reliance Trust's 13F filing for Q1 2015, filed 24 Apr 2015.